Tumor Microenvironment and Brain Metastases in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer

被引：0
|
作者：
Zhang, Qin [1 ]
Fu, Xiaolong [1 ]
Cai, Xuwei [1 ]
Feng, Wen [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Radiat Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Tumor Budding; brain metastases; stage IIIA(N2) NSCLC; tumor-infiltrating lymphocytes;
D O I：
10.1016/j.jtho.2016.11.419
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA06.06
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [41] The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer
    Luo, Lumeng
    Liu, Peiyi
    Zhao, Kuaile
    Zhao, Weixin
    Zhang, Xiaofei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Prognostic Value of Preoperative N Subcategories in Patients with Stage IIIA N2 Non-Small Cell Lung Cancer
    Oh, Na Eun
    Choe, Jooae
    Yun, Jae Kwang
    Ji, Wonjun
    Kim, Seonok
    Chae, Eun Jin
    Lee, Sang Min
    Seo, Joon Beom
    RADIOLOGY-CARDIOTHORACIC IMAGING, 2024, 6 (04):
  • [43] Prognostic significance of the number of tumor (+) N2 nodes in N2 stage IIIA non-small cell lung cancer after curative resection.
    Yoo, C.
    Yoon, S.
    Lee, D.
    Suh, C.
    Lee, J.
    Park, S.
    Kim, D.
    Kim, Y.
    Kim, W.
    Kim, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Tumor Immune Microenvironment Profiling in Oligometastatic Non-Small Cell Lung Cancer with Brain Metastases
    Werner, R. S.
    Moch, H.
    Weller, M.
    Weiss, T.
    Regli, L.
    Le Rhun, E.
    Curioni-Fontecedro, A.
    Opitz, I.
    Soltermann, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S86 - S87
  • [45] Patterns of Local-Regional Failure in Completely Resected Stage IIIa (N2) Non-Small Cell Lung Cancer Patients: Implications for Postoperative Radiation Therapy Target Volumes
    Feng, W.
    Fu, X.
    Hua, Y.
    Yang, H.
    Zhu, Z.
    Cai, X.
    Jiang, G.
    Zhang, Y.
    Xiang, J.
    Chen, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S521 - S521
  • [46] Feasibility and Safety of the Clinical Target Volume Design for Postoperative Radiation Therapy in Completely Resected Stage IIIA(N2) Non-Small Cell Lung Cancer: A Prospective Validation Study
    Feng, W.
    Zhang, Q.
    Yu, W.
    Cai, X. W.
    Fu, X. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E445 - E445
  • [47] Clinical presentation of stage IIIA (N2) non-small cell lung cancer - Role of multimodality therapy
    Friedberg, JS
    CHEST, 1999, 116 (06) : 497S - 499S
  • [48] Is trimodality approach better then bimodality in stage IIIA, N2 positive non-small cell lung cancer?
    Park, Byeong-Bae
    Park, Joon Oh
    Kim, Hojoong
    Ahn, Yong Chan
    Choi, Yong Soo
    Kim, Kwhanmien
    Kim, Jhingook
    Shim, Young Mog
    Ahn, Jin Seok
    Park, Keunchil
    LUNG CANCER, 2006, 53 (03) : 323 - 330
  • [49] The impact of extent of nodal involvement on stage IIIA (N2) non-small cell lung cancer outcomes
    Wong, Lye-Yeng
    Tsai, Lillian L.
    He, Hao
    Elliott, Irmina A.
    Berry, Mark F.
    JTCVS OPEN, 2025, 23 : 256 - 265
  • [50] Outcomes of surgical treatment for unsuspected N2 (pathologic stage IIIA) non-small cell lung cancer
    Kim, Hong Kwan
    Park, Joon Suk
    Choi, Yong Soo
    Kim, Kwhanmien
    Kim, Jhingook
    Shim, Young Mog
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S568 - S569
12345